Tag Archive for: POC study

Sepsis

Adrenomed set to start pivotal trial in sepsis

German Adrenomed AG has got a recommendation from the EMA to push its Adrenomedullin-binding antibody Adrecizumab into a pivotal Phase III study.

Read more